Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
SNOA Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
18.20%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
SNOA Stock Analysis
SNOA
PE Ratio:
SNOA
PEG Ratio:
Not Available
SNOA
Forward EPS Growth (12 month):
0.00%
SNOA
PS Ratio:
0.1
SNOA
PSG Ratio:
SNOA
Forward Revenue Growth (12 month):
24.60%
SNOA Articles
No data was found